WA People
BILL · 2017–18 SESSION · LATEST VERSION 2SSB 5586

SB 5586: Rx drug cost transparency

Addressing prescription drug cost transparency.

Summary

  • Requires issuers and drug manufacturers to report certain prescription drug pricing data on a yearly basis to a data organization contracted by the Office of Financial Management (OFM).
  • Requires drug manufacturers to report price increases and written justification for the increase to purchasers.
  • Requires the data organization to summarize the prescription drug pricing data and provide reports to the Legislature.

From the Senate Bill Report (SB 5586), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · stalled on the Senate floor
  1. IntroducedJan 30, 2017
  2. Out of committeeFeb 6, 2018
  3. Passed Senatestopped here
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Kevin Ranker (D-40)
Introduced
January 30, 2017 in the Senate
Last action
February 22, 2018
Budget
Has a fiscal note
Versions
SB 5586, SSB 5586, 2SSB 5586

AN ACT Relating to prescription drug cost transparency;

Sponsors

Prime sponsor: Kevin Ranker (D-40)

9 co-sponsors (7 Democrats, 2 Republicans)

Senator R-18Patty Kuderer D-48Annette Cleveland D-49Mark Miloscia R-30Mark Mullet D-5Rebecca Saldaña D-37Karen Keiser D-33Steve Conway D-29Bob Hasegawa D-11

Votes

No recorded floor votes.

History

  1. Senate Rules "X" file. (2SSB 5586)
  2. Senate Rules "X" file. (SSB 5586)
  3. Senate Rules "X" file.
  4. Placed on second reading by Rules Committee. (2SSB 5586)
  5. Placed on second reading by Rules Committee. (SSB 5586)
  6. Placed on second reading by Rules Committee.
  7. Passed to Rules Committee for second reading. (2SSB 5586)
  8. Minority; without recommendation. (2SSB 5586)
  9. WM - Majority; 2nd substitute bill be substituted, do pass. (2SSB 5586)
  10. WM - Majority; 2nd substitute bill be substituted, do pass. (SSB 5586)
  11. Minority; without recommendation. (SSB 5586)
  12. Passed to Rules Committee for second reading. (SSB 5586)
  13. Passed to Rules Committee for second reading.
  14. Minority; without recommendation.
  15. WM - Majority; 2nd substitute bill be substituted, do pass.
  16. Referred to Ways & Means. (SSB 5586)
  17. Referred to Ways & Means.
  18. HLTC - Majority; 1st substitute bill be substituted, do pass. (SSB 5586)
  19. Minority; without recommendation. (SSB 5586)
  20. And refer to Ways & Means. (SSB 5586)
  21. Minority; do not pass. (SSB 5586)
  22. Minority; do not pass.
  23. And refer to Ways & Means.
  24. Minority; without recommendation.
  25. HLTC - Majority; 1st substitute bill be substituted, do pass.
  26. Due to Senate committee reorganization, referred to Health & Long Term Care.
  27. By resolution, reintroduced and retained in present status.
  28. By resolution, reintroduced and retained in present status.
  29. By resolution, reintroduced and retained in present status.
  30. By resolution, reintroduced and retained in present status.
  31. First reading, referred to Health Care.

SB 5586 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page